Lung Cancer: An Evidence-Based Approach to Multidisciplinary Management
Editat de Erin Alexis Gillaspie, Leora Horn, Amanda S. Cassen Limba Engleză Hardback – 11 oct 2023
- Discusses key topics such as small cell and non-small cell lung cancers; immunotherapy, molecular cohorts including ROS1, BRAF, HER2, Met, and NTRK; oligometastatic disease; and more
- Covers individualized treatment plans for chemotherapy, radiotherapy, targeted biomarker-derived therapies, and new and emerging immunotherapies
- Provides excellent visual guidance throughout, including algorithms, pathology specimens, anatomic drawings, and PET/CT and CT imaging for diagnosis and treatment planning
- Features "Top 5 Clinical Pearls" at the beginning of each chapter
- Shares the experience and knowledge of medical oncologists, radiation oncologists, surgical oncologists, and thoracic radiologists for a real-world tumor board perspective
- An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud
Preț: 1185.27 lei
Preț vechi: 1560.07 lei
-24%
Puncte Express: 1778
Carte tipărită la comandă
Livrare economică 30 septembrie-14 octombrie
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9780323695732
ISBN-10: 0323695736
Pagini: 352
Dimensiuni: 152 x 229 mm
Greutate: 0.68 kg
Editura: Elsevier
ISBN-10: 0323695736
Pagini: 352
Dimensiuni: 152 x 229 mm
Greutate: 0.68 kg
Editura: Elsevier
Cuprins
1. Lung Cancer Screening and Prevention
2. Lung Cancer: Diagnostic Techniques
3. Histology and Molecular Testing
4. Surgical Considerations in Lung Cancer Treatment
5. Surgically Resectable Disease
6. Oligometastatic Disease
7. Locally Advanced Non-Small Cell Lung Cancer
8. First-Line Therapy
9. Second-Line Therapy in Advanced Non-Small Cell Lung Cancer
10. Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Clinical Approach
11. Diagnosis and Treatment of Anaplastic Lymphoma Kinase (ALK)Rearranged Non2Small Cell Lung Cancer
12. Other Molecular Cohorts Including ROS1, BRAF, HER2, MET, NTRK, RET, KRAS
13. Immunotherapy
14. Small Cell Lung Cancer
2. Lung Cancer: Diagnostic Techniques
3. Histology and Molecular Testing
4. Surgical Considerations in Lung Cancer Treatment
5. Surgically Resectable Disease
6. Oligometastatic Disease
7. Locally Advanced Non-Small Cell Lung Cancer
8. First-Line Therapy
9. Second-Line Therapy in Advanced Non-Small Cell Lung Cancer
10. Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Clinical Approach
11. Diagnosis and Treatment of Anaplastic Lymphoma Kinase (ALK)Rearranged Non2Small Cell Lung Cancer
12. Other Molecular Cohorts Including ROS1, BRAF, HER2, MET, NTRK, RET, KRAS
13. Immunotherapy
14. Small Cell Lung Cancer